Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Molins

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
Epilepsy & Behavior : E&B|June 15, 2015
EEG extreme delta brush: An ictal pattern in patients with anti-NMDA receptor encephalitisM Veciana, J L Becerra, P Fossas, et al.
Acta Neurologica Scandinavica|March 25, 2018
Retrospective study of perampanel efficacy and tolerability in myoclonic seizuresF J Gil-López, J Montoya, M Falip, et al.
Epilepsy Research|June 9, 2014
Long-term safety and efficacy of eslicarbazepine acetate in patients with focal seizures: results of the 1-year ESLIBASE retrospective studyV Villanueva, J M Serratosa, E Guillamón, et al.
Seizure|April 19, 2017
Efficacy and safety of eslicarbazepine-acetate in elderly patients with focal epilepsy: Case seriesA Gómez-Ibáñez, J M Serratosa, E Guillamón, et al.
Epilepsy Research|December 27, 2016
Erratum to "Safety, efficacy and outcome-related factors of perampanel over 12months in a real-world setting: The FYDATA study" [Epilepsy Res. 126 (2016) 201-210]V Villanueva, M Garcés, F J López-González, et al.
Epilepsy Research|August 14, 2016
Safety, efficacy and outcome-related factors of perampanel over 12 months in a real-world setting: The FYDATA studyV Villanueva, M Garcés, F J López-González, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Epilepsy & Behavior : E&B|June 15, 2015
EEG extreme delta brush: An ictal pattern in patients with anti-NMDA receptor encephalitisM Veciana, J L Becerra, P Fossas, et al.
Acta Neurologica Scandinavica|March 25, 2018
Retrospective study of perampanel efficacy and tolerability in myoclonic seizuresF J Gil-López, J Montoya, M Falip, et al.
Epilepsy Research|June 9, 2014
Long-term safety and efficacy of eslicarbazepine acetate in patients with focal seizures: results of the 1-year ESLIBASE retrospective studyV Villanueva, J M Serratosa, E Guillamón, et al.
Seizure|April 19, 2017
Efficacy and safety of eslicarbazepine-acetate in elderly patients with focal epilepsy: Case seriesA Gómez-Ibáñez, J M Serratosa, E Guillamón, et al.
Epilepsy Research|December 27, 2016
Erratum to "Safety, efficacy and outcome-related factors of perampanel over 12months in a real-world setting: The FYDATA study" [Epilepsy Res. 126 (2016) 201-210]V Villanueva, M Garcés, F J López-González, et al.
Epilepsy Research|August 14, 2016
Safety, efficacy and outcome-related factors of perampanel over 12 months in a real-world setting: The FYDATA studyV Villanueva, M Garcés, F J López-González, et al.
Pageof 8